BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 7508221)

  • 1. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
    Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
    Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide toxicity-regulating proteins in bacteremia.
    Froon AH; Dentener MA; Greve JW; Ramsay G; Buurman WA
    J Infect Dis; 1995 May; 171(5):1250-7. PubMed ID: 7538550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
    Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S
    Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative concentrations of endotoxin-binding proteins in body fluids during infection.
    Opal SM; Palardy JE; Marra MN; Fisher CJ; McKelligon BM; Scott RW
    Lancet; 1994 Aug; 344(8920):429-31. PubMed ID: 7520106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J
    J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
    J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P; Weiss J
    Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide-binding protein and bactericidal/permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes.
    Sundaram S; King AJ; Pereira BJ
    J Am Soc Nephrol; 1997 Mar; 8(3):463-70. PubMed ID: 9071715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
    Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of changes in plasma bactericidal/permeability-increasing protein levels in patients with severe surgical infection].
    Zhang LT; Yao YM; Lu JQ; Yu Y
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1342-5. PubMed ID: 18241571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.
    Mao Y; Zhou C; Zhu L; Huang Y; Yan T; Fang J; Zhu W
    Fish Shellfish Immunol; 2013 Sep; 35(3):642-52. PubMed ID: 23742867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
    Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
    Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains.
    Iovine NM; Elsbach P; Weiss J
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10973-8. PubMed ID: 9380744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein.
    Horwitz AH; Williams RE; Nowakowski G
    Infect Immun; 1995 Feb; 63(2):522-7. PubMed ID: 7822017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis.
    Juffermans NP; Verbon A; van Deventer SJ; Buurman WA; van Deutekom H; Speelman P; van der Poll T
    J Infect Dis; 1998 Dec; 178(6):1839-42. PubMed ID: 9815247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction.
    Hubacek JA; Pitha J; Skodová Z; Adámková V; Podrapska I; Schmitz G; Poledne R
    Clin Chem Lab Med; 2002 Nov; 40(11):1097-100. PubMed ID: 12521224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.
    Marra MN; Thornton MB; Snable JL; Leong S; Lane J; Wilde CG; Scott RW
    Blood Purif; 1993; 11(2):134-40. PubMed ID: 7506040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis.
    Hubacek JA; Stüber F; Fröhlich D; Book M; Wetegrove S; Ritter M; Rothe G; Schmitz G
    Crit Care Med; 2001 Mar; 29(3):557-61. PubMed ID: 11373419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.
    Pereira BJ; Sundaram S; Snodgrass B; Hogan P; King AJ
    J Am Soc Nephrol; 1996 Mar; 7(3):479-87. PubMed ID: 8704115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.